GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » BeOne Medicines Ltd (BSP:B1ME34) » Definitions » Cyclically Adjusted FCF per Share

BeOne Medicines (BSP:B1ME34) Cyclically Adjusted FCF per Share : R$-2.64 (As of Mar. 2025)


View and export this data going back to 2020. Start your Free Trial

What is BeOne Medicines Cyclically Adjusted FCF per Share?

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted FCF per Share and the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years.

BeOne Medicines's adjusted free cash flow per share for the three months ended in Mar. 2025 was R$-0.150. Add all the adjusted free cash flow per share for the past 10 years together and divide the count will get our Cyclically Adjusted FCF per Share, which is R$-2.64 for the trailing ten years ended in Mar. 2025.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted FCF Growth Rate using Cyclically Adjusted FCF per Share data.

As of today (2025-06-01), BeOne Medicines's current stock price is R$52.45. BeOne Medicines's Cyclically Adjusted FCF per Share for the quarter that ended in Mar. 2025 was R$-2.64. BeOne Medicines's Cyclically Adjusted Price-to-FCF of today is .


BeOne Medicines Cyclically Adjusted FCF per Share Historical Data

The historical data trend for BeOne Medicines's Cyclically Adjusted FCF per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

BeOne Medicines Cyclically Adjusted FCF per Share Chart

BeOne Medicines Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Cyclically Adjusted FCF per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -2.80

BeOne Medicines Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Cyclically Adjusted FCF per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -2.31 -2.62 -2.57 -2.80 -2.64

Competitive Comparison of BeOne Medicines's Cyclically Adjusted FCF per Share

For the Biotechnology subindustry, BeOne Medicines's Cyclically Adjusted Price-to-FCF, along with its competitors' market caps and Cyclically Adjusted Price-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


BeOne Medicines's Cyclically Adjusted Price-to-FCF Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, BeOne Medicines's Cyclically Adjusted Price-to-FCF distribution charts can be found below:

* The bar in red indicates where BeOne Medicines's Cyclically Adjusted Price-to-FCF falls into.


;
;

BeOne Medicines Cyclically Adjusted FCF per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted FCF per Share and the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years.

What is Cyclically Adjusted FCF per Share? How do we calculate Cyclically Adjusted FCF per Share?

Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted FCF per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the free cash flow per share from 2001 through 2010.

We adjusted the 2001 free cash flow per share data with the total inflation from 2001 through 2010 to the equivalent free cash flow in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's free cash flow is $1 a share in 2001, then the 2001's equivalent free cash flow in 2010 is $1.4 a share. If Wal-Mart's free cash flow is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 free cash flow in 2010 is $1.35. So on and so forth, you get the equivalent free cash flow per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted FCF per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, BeOne Medicines's adjusted Free Cash Flow per Share data for the three months ended in Mar. 2025 was:

Adj_FreeCashFlowPerShare= Free Cash Flow per Share /CPI of Mar. 2025 (Change)*Current CPI (Mar. 2025)
=-0.15/107.7224*107.7224
=-0.150

Current CPI (Mar. 2025) = 107.7224.

BeOne Medicines Quarterly Data

Free Cash Flow per Share CPI Adj_FreeCashFlowPerShare
201506 -0.017 100.464 -0.018
201509 -0.031 99.785 -0.033
201512 -0.099 99.386 -0.107
201603 -0.151 99.475 -0.164
201606 -0.103 100.088 -0.111
201609 -0.122 99.604 -0.132
201612 -0.129 99.380 -0.140
201703 -0.136 100.040 -0.146
201706 -0.217 100.285 -0.233
201709 -0.033 100.254 -0.035
201712 0.217 100.213 0.233
201803 -0.316 100.836 -0.338
201806 -0.359 101.435 -0.381
201809 -0.460 101.246 -0.489
201812 -0.725 100.906 -0.774
201903 -0.574 101.571 -0.609
201906 -0.226 102.044 -0.239
201909 -0.811 101.396 -0.862
201912 -0.819 101.063 -0.873
202003 -1.027 101.048 -1.095
202006 -0.789 100.743 -0.844
202009 -1.030 100.585 -1.103
202012 -0.876 100.241 -0.941
202103 0.173 100.800 0.185
202106 -1.005 101.352 -1.068
202109 -1.281 101.533 -1.359
202112 -1.585 101.776 -1.678
202203 -0.693 103.205 -0.723
202206 -0.845 104.783 -0.869
202209 -1.400 104.835 -1.439
202212 -0.987 104.666 -1.016
202303 -1.379 106.245 -1.398
202306 -0.771 106.576 -0.779
202309 -0.481 106.570 -0.486
202312 -0.732 106.461 -0.741
202403 -0.958 107.355 -0.961
202406 -0.423 107.991 -0.422
202409 0.114 107.468 0.114
202412 -0.039 107.128 -0.039
202503 -0.150 107.722 -0.150

Add all the adjusted free cash flow per share together and divide 10 will get our Cyclically Adjusted FCF per Share.


BeOne Medicines  (BSP:B1ME34) Cyclically Adjusted FCF per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted FCF per Share may underestimate the company's free cash flow. Cyclically Adjusted Price-to-FCF can seem to be too high even the actual Price-to-Free-Cash-Flow is low.

For the Cyclically Adjusted Price-to-FCF, the free cash flow per share of the past 10 years are inflation-adjusted and averaged. The result is used for P/FCF calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted Price-to-FCF is also called CAPFCF Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted free cash flow per share of a company over the past 10 years.


Be Aware

Cyclically Adjusted Price-to-FCF works better for cyclical companies. It gives you a better idea on the company's real free cash flow value.


BeOne Medicines Cyclically Adjusted FCF per Share Related Terms

Thank you for viewing the detailed overview of BeOne Medicines's Cyclically Adjusted FCF per Share provided by GuruFocus.com. Please click on the following links to see related term pages.


BeOne Medicines Business Description

Industry
Address
c/o BeOne Medicines I GmbH, Aeschengraben 27, 21st Floor, Basel, CHE, 4051
Founded in 2010 in Beijing and having listed on the Hong Kong exchange in 2018, BeiGene is a commercial-stage biotechnology company with global sales. It focuses on oncology therapeutics and differentiates itself from other companies with a contract research organization-free, or CRO-free strategy. BeiGene runs global clinical trials with its own team. As of 2024, its core drug is Brukinsa, a small molecule drug for various blood cancers that makes up more than 60% of BeiGene's revenue.

BeOne Medicines Headlines

No Headlines